Table 1 Summary of the incidence of acute and chronic GVHD, and rates of treatment-related mortality and response in studies of stem cell transplantation for metastatic RCC
Study | Number of patients | Acute GVHD number (%) | Chronic GVHD number (%) | TRM rate number (%) | Response rate number (%) |
|---|---|---|---|---|---|
19 | 10 (53) | 4 (21) | 2 (11) | 10 (53) | |
Pedrazzoli et al.5 | 8 | 0 | 0 | 2 (25) | 0 |
Bregni et al.6 | 7 | 6 (86) | 5 (71) | 1 (14) | 4 (57) |
Hentschke et al.7 | 10 | 5 (50) | 3 (30) | 3 (30) | 3 (30) |
Baron et al.8 | 7 | 3 (43) | 1 (14) | 0 | 1 (14) |
Aoyama et al.19 | 2 | 1 (50) | 0 | 0 | 1 (50) |
Ueno et al.9 | 15 | 7 (47) | 4 (27) | 5 (33) | 3 (20) |
Blaise et al.10 | 25 | 4 (17) | 7 (28) | No data | 2 (8) |
Bornhauser et al.20 | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) |
Takami et al.21 | 3 | 2 (67) | 2 (67) | 2 (67) | 2 (67) |
Nakagawa et al.11 | 9 | 3 (33) | 4 (44) | 0 | 1 (11) |
Massenkeil et al.12 | 7 | 2 (29) | 4 (57) | 1 (14) | 2 (29) |
Tykodi et al.13 | 8 | 4 (50) | 4 (50) | 1 (13) | 1 (13) |
Secondino et al.22 | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) |
18 | 3 (17) | 7 (39) | 6 (33) | 4 (22) | |
Rzepecki et al.17 | 5 | 3 (60) | 0 | 0 | 0 |
Rini et al. (CALGB)18 | 22 | 11 (50) | 5 (23) | 2 (9) | 0 |
